Join uBriGene’s
Educational Live Webinars on ATMPs
Live Webinars on the Development and cGMP manufacturing of Advanced Therapy Medicinal Products
uBriGene is your bridge from ATMPs concept to commercialization. We have 4 Centers of Manufacturing Excellence: cell therapy (CAR-T, CAR-NK, iPSC, MSC), plasmids, viral vectors (AAV, lentiviral vectors, retroviral vectors, adenovirus), and mRNA.
We are pleased to sponsor an educational series on the basics of advanced therapy development and manufacturing.
Lentiviral Vector Basics
June 2024 Webinar: Lentiviral vector basics for cell therapy applications
The goal of this webinar is to:
- Understand the basics of Lentiviral Vector (LV): definition and characteristics of LV, and their mechanism of action in gene-modified cell therapies.
- Explore current manufacturing approaches for LV: an overview of existing platforms and technologies, as well as key considerations in LV production scalability and efficiency.
- Discuss strategies to accelerate LV deployment in cell therapy: the importance of early identification of critical raw materials, and criteria for selecting a proven manufacturing platform, also impact on time-to-market and therapeutic accessibility
Presenter: Kenneth Warrington, Ph.D., Executive Director, Strategic Business Development, Head of Technical Services.
CAR-T Therapy 101
April 2024 Webinar: “CAR-T 101”, the basics of CAR-T therapies, from concepts to GMP manufacturing.
In the first presentation, you will gain a comprehensive understanding of CAR-T therapies, including:
- The general requirements for the development of CAR-T therapies
- General approaches to gene modification of T-cells
- High level discussion of GMP manufacturing workflows
- Regulatory considerations for clinical application of these therapies
Presenter: Kenneth Warrington, Ph.D., Executive Director, Strategic Business Development, Head of Technical Services.